SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum
GLD 386.01+1.6%4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TobagoJack who wrote (82184)10/27/2011 5:34:39 AM
From: Arran Yuan  Read Replies (1) of 217729
 
The bio-biz is flourishing here in the mainland in general.

Genetic engineering is widely use at cell and microbe level for products used as reagents, small biz companies and workshops are of a good number. It is also true for genetic diagnosis except for Huada Genes, of a medium size but no positive cash flow biz model. And, of course, Monsanto infiltrated into bean, bean oil, corn, cotton, and rice, which is under hot debate.

Policies guarding bio-tech application to humans are more or less at similar stringency compared to those of the developed countries, with variations here and there.

As a visiting prof. of toxicology of a major university, I can say that university/institute r n d in bio-biz is still at its budding stage. Biotech companies of univ.-institute affiliation are few with good biz model. The other side of this story is that members of faculty are enjoying a relatively large degree of freedom to set up startups.

Our team owns patented techies to generate enough cells from a single cord blood sample to ten to the ninth range, an generally accepted effective dose for clinical treatment. Regulations are set at level-3 new treatment for cell-based treatments, a relatively easy to satisfy level.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News